Top news of the week: 13.07.2021.
Healthcare
Biotech 'Strikes Again,' Identifies Gene Mutation that Protects Against Obesity
The encouraging work Regeneron Pharmaceuticals completed thus far, and the next challenge in this program, are laid out in an H.C. Wainwright & Co. report.
China’s gene giant harvests data from millions of women
A prenatal test used worldwide sends gene data of pregnant women to the company that developed it with China's military. The U.S. sees a security risk.
BioSpace Movers & Shakers, July 9
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
‘Too good to be true’: Doubts swirl around trial that saw 77% reduction in COVID-19 mortality
Preprint from Brazil claims spectacular results from experimental prostate cancer drug
Celldex pins its hopes for a comeback on skin disease drug
After several setbacks, most notably the failure of a brain cancer vaccine, Celldex has a chance at reinvention should early drug results pan out for the 16-year-old biotech.
FDA Approves J&J’s Darzalex Faspro for Sixth Multiple Myeloma Indication
It was based on data from the APOLLO trial showing the drug significantly decreased the risk of progression or death by 37 percent compared to dexamethasone alone.
Why we must remove barriers to trade to achieve vaccine equity (Step 3)
To put an end to the pandemic, industry was tasked with manufacturing and supplying billions of COVID-19 vaccines, starting from zero. This monumental task is on its way to being achieved, ...
Life Sciences Vision
Any enquiries regarding this publication should be sent to us at: [email protected] 1Life Sciences Vision Contents Foreword – Prime Minister Rt Hon Boris Johnson, MP 3 …